Stem cell and drug discovery scientists around the world are using our solutions to translate their research into therapies
REPROCELL offers a variety of ready-to-ship products to support Mesenchymal Stem Cell (MSC) research, including iPSC-derived cell lines, media, and other culture reagents. Our cell lines are useful for differentiation and exosome production to promote a variety of disease models for research.
Mesenchymal Stem Cells (MSCs) are involved in a variety of cell therapy and drug discovery programs. REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies.
Human Tissue Pharmacology
Human fresh tissue testing bridges the gap between animal studies and clinical trials. We specialize in proof of concept studies in patient-derived living tissues, increasing your clinical success rates and adding commercial value to your preclinical drug assets.
Stem Cell Services for Cell Therapy Manufacturing
GMP iPSC and MSC Master Cell Banks and cells for your cell therapy project. Compliant with regulatory standards of the FDA, EMA, and PDMA.
Alvetex® Bioengineered 3D Tissue Services
Complementing our fresh tissue assays by accurately recreating human biology in bioengineered tissues.
StemEdit Clinical Gene Editing Service
Achieve the genotype you need using CRISPR-SNIPER, before moving on to expensive cell bank manufacturing processes.
Oligonucleotide Synthesis Services
Exceptional quality oligos, delivered worldwide. Custom synthesis, purification, and modification – all based on your requirements.
On the REPROCELL blog
Latest
The Power of Human Tissue Models in Preclinical Research
03 October 2024
Understanding Safety Pharmacology in Human Tissues
26 August 2024
Nucleic Acid Extraction in Clinical Research
08 August 2024
Upcoming Events
Conferences we will be attending, and webinars hosted by us
CONFERENCE
The Cell & Gene Meeting on the Mesa 2024
7-9 October (in person) & 10-11 October (virtual)
Phoenix, AZ
Corporate News
%20vial.jpg)
